178 related articles for article (PubMed ID: 9503485)
21. Micromolar taxol, with or without hyperthermia, induces mitotic catastrophe and cell necrosis in HeLa cells.
Michalakis J; Georgatos SD; Romanos J; Koutala H; Georgoulias V; Tsiftsis D; Theodoropoulos PA
Cancer Chemother Pharmacol; 2005 Dec; 56(6):615-22. PubMed ID: 16025289
[TBL] [Abstract][Full Text] [Related]
22. The schedule-dependent effects of etoposide in leukaemic cell lines: a function of concentration and duration.
Liu WM; Joel SP
Cancer Chemother Pharmacol; 2003 Apr; 51(4):291-6. PubMed ID: 12721756
[TBL] [Abstract][Full Text] [Related]
23. Irradiation and various cytotoxic drugs enhance tyrosine phosphorylation and beta(1)-integrin clustering in human A549 lung cancer cells in a substratum-dependent manner in vitro.
Cordes N; Beinke C; Plasswilm L; van Beuningen D
Strahlenther Onkol; 2004 Mar; 180(3):157-64. PubMed ID: 14991204
[TBL] [Abstract][Full Text] [Related]
24. Taxol and radiation.
Geard CR; Jones JM; Schiff PB
J Natl Cancer Inst Monogr; 1993; (15):89-94. PubMed ID: 7912535
[TBL] [Abstract][Full Text] [Related]
25. Treatment with paclitaxel alone rather than combination with paclitaxel and cisplatin may be selective for cisplatin-resistant ovarian carcinoma.
Yamamoto K; Kikuchi Y; Kudoh K; Hirata J; Kita T; Nagata I
Jpn J Clin Oncol; 2000 Oct; 30(10):446-9. PubMed ID: 11185891
[TBL] [Abstract][Full Text] [Related]
26. Difluoromethylornithine antagonizes taxol cytotoxicity in MCF-7 human breast cancer cells.
Das B; Rao AR; Madhubala R
Oncol Res; 1997; 9(11-12):565-72. PubMed ID: 9563003
[TBL] [Abstract][Full Text] [Related]
27. Low-dose fractionated radiation potentiates the effects of Paclitaxel in wild-type and mutant p53 head and neck tumor cell lines.
Dey S; Spring PM; Arnold S; Valentino J; Chendil D; Regine WF; Mohiuddin M; Ahmed MM
Clin Cancer Res; 2003 Apr; 9(4):1557-65. PubMed ID: 12684432
[TBL] [Abstract][Full Text] [Related]
28. Murine intestinal crypt survival after combined taxol plus radiation exposure.
Lojun SL; Sigdestad CP; Connor AM; Spanos WJ; Bosscher JR
Gynecol Oncol; 1996 Nov; 63(2):180-3. PubMed ID: 8910624
[TBL] [Abstract][Full Text] [Related]
29. Functional p53 increases prostate cancer cell survival after exposure to fractionated doses of ionizing radiation.
Scott SL; Earle JD; Gumerlock PH
Cancer Res; 2003 Nov; 63(21):7190-6. PubMed ID: 14612513
[TBL] [Abstract][Full Text] [Related]
30. Paclitaxel enhanced radiation sensitization for the suppression of human prostate cancer tumor growth via a p53 independent pathway.
Zhang AL; Russell PJ; Knittel T; Milross C
Prostate; 2007 Nov; 67(15):1630-40. PubMed ID: 17823933
[TBL] [Abstract][Full Text] [Related]
31. Cell cycle-dependent antagonistic interactions between paclitaxel and gamma-radiation in combination therapy.
Sui M; Dziadyk JM; Zhu X; Fan W
Clin Cancer Res; 2004 Jul; 10(14):4848-57. PubMed ID: 15269161
[TBL] [Abstract][Full Text] [Related]
32. Taxol sensitizes human ovarian cancer cells to radiation.
Steren A; Sevin BU; Perras J; Angioli R; Nguyen H; Guerra L; Koechli O; Averette HE
Gynecol Oncol; 1993 Feb; 48(2):252-8. PubMed ID: 8094062
[TBL] [Abstract][Full Text] [Related]
33. Paclitaxel and N-methylformamide: in vitro interactions in human colon cancer cell line.
Valenti AM; Niero A; Monti G; Marangolo F; Marangolo M
Anticancer Res; 1997; 17(4A):2491-7. PubMed ID: 9252669
[TBL] [Abstract][Full Text] [Related]
34. Proliferation and clonal survival of human lung cancer cells treated with fractionated irradiation in combination with paclitaxel.
van Rijn J; van den Berg J; Meijer OW
Int J Radiat Oncol Biol Phys; 1995 Oct; 33(3):635-9. PubMed ID: 7558953
[TBL] [Abstract][Full Text] [Related]
35. Effect of treatment schedule on the interaction of Cisplatin and radiation in human lung cancer cells.
Asaka-Amano Y; Takiguchi Y; Yatomi M; Kurosu K; Kasahara Y; Tanabe N; Tatsumi K; Kuriyama T
Radiat Res; 2007 Jun; 167(6):637-44. PubMed ID: 17523845
[TBL] [Abstract][Full Text] [Related]
36. Aggressive simultaneous radiochemotherapy with cisplatin and paclitaxel in combination with accelerated hyperfractionated radiotherapy in locally advanced head and neck tumors. Results of a phase I-II trial.
Kuhnt T; Becker A; Pigorsch S; Pelz T; Bloching M; Passmann M; Lotterer E; Hänsgen G; Dunst J
Strahlenther Onkol; 2003 Oct; 179(10):673-81. PubMed ID: 14566475
[TBL] [Abstract][Full Text] [Related]
37. Enhancement of intrinsic tumor cell radiosensitivity induced by a selective cyclooxygenase-2 inhibitor.
Petersen C; Petersen S; Milas L; Lang FF; Tofilon PJ
Clin Cancer Res; 2000 Jun; 6(6):2513-20. PubMed ID: 10873107
[TBL] [Abstract][Full Text] [Related]
38. Host cell cytotoxicity, cellular repopulation dynamics, and phase-specific cell survival in X-irradiated rat rhabdomyosarcoma tumors.
Tenforde TS; Kavanau KS; Afzal SM; Curtis SB
Radiat Res; 1990 Jul; 123(1):32-43. PubMed ID: 2371379
[TBL] [Abstract][Full Text] [Related]
39. Effects of paclitaxel in combination with ionizing radiation on angiogenesis in the chick embryo chorioallantoic membrane. A radiobiological study.
Kardamakis D; Hadjimichael C; Ginopoulos P; Papaioannou S
Strahlenther Onkol; 2004 Mar; 180(3):152-6. PubMed ID: 14991203
[TBL] [Abstract][Full Text] [Related]
40. Comparison of the effectiveness of tirapazamine and carbogen with nicotinamide in enhancing the response of a human tumor xenograft to fractionated irradiation.
el-Said A; Menke D; Dorie MJ; Brown JM
Radiat Oncol Investig; 1999; 7(3):163-9. PubMed ID: 10406058
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
